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Abstract Human immunodeficiency virus (HIV) glycoprotein
(gp) 160 processing by host cell proteinases is an essential step
for viral fusion and infectivity. We have identified a rat liver
subcellular fraction which specifically processes gp160 into
gp120 and gp41. Using equilibration of microsomes in sucrose
gradients, the gp160 cleavage activity was associated with
particles equilibrating at low densities, well-separated from the
endoplasmic reticulum, cis-Golgi network, Golgi stacks, lyso-
somes and plasma membrane. Its density distribution was
compatible with light secretory vesicles derived from the trans-
Golgi network (TGN) or to endosomes, but association with
endosomes was not supported by free flow electrophoresis.
Although furin and pro-protein convertase (PC) 7/LPC have
been proposed as the major gp160 processing convertases, the rat
liver microsomal gp160 processing activity was essentially
resolved from furin and only partially overlapped PC7/LPC.
These data suggest that proteinase(s) other than furin and PC7/
LPC, presumably located in TGN-derived vesicles, may parti-
cipate in the gp160 processing into gp120 and gp41.
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1. Introduction
Critical steps in human immunode¢ciency virus (HIV) in-
fection include binding and fusion with CD4-positive cells.
Fusion between the virus and host cell membranes involves
both viral envelope glycoproteins gp120 and gp41 [1]. These
HIV-1 envelope glycoproteins are synthesized as an inactive
precursor gp160 that is cleaved at the conserved sequence R-
E-K-RsA-V during its transport through the host cell secre-
tory pathway. Correct endoproteolytic maturation of gp160 is
essential for the fusion process, hence for viral infectivity. The
cleavage capacity has been tentatively assigned to the cis/me-
dial cisternae of the Golgi complex [2,3] or to secretory
vesicles [4,5]. Clear-cut genetic evidence of the participation
of any endoprotease to gp160 processing in vivo is lacking.
The family of kexin/subtilisin-like serine proteinases is im-
plicated in the endoproteolytic maturation of protein precur-
sors at sequences (R-X-K/R-Rs), similar to that found in the
classical cleavage site of gp160, located at the carboxy-termi-
nal of Arg511. Members of this family, also known as pro-
protein convertases (PCs), include furin, PC1/3, PC2, paired
basic amino acids converting enzyme (PACE) 4, PC4, PC5/6
and PC7/LPC [6,7]. Two such convertases, furin and PC7/
LPC, have been suggested as the best candidates for gp160
processing in infected lymphocytes [8].
Furin was ¢rst shown to be able to cleave gp160 into gp120/
gp41 using the vaccinia virus overexpression system [9], but
recent studies have implicated other members of the mamma-
lian PC family in this process. Speci¢c cleavage of gp160 has
been demonstrated by in vitro assays with furin, PC1/3,
PACE4 and PC5/6 and in co-expression studies for furin,
PACE4, PC5/6 and PC7/LPC [8,10^12]. However, involve-
ment of a convertase in the maturation process of a given
substrate requires its co-localization with the substrate in
the subcellular compartment where cleavage normally takes
place. Since overexpression used in the afore-mentioned stud-
ies may saturate retention/retrieval mechanisms and thereby
alter intracellular protein targeting [13], a de¢nitive proof is
still lacking that these convertases normally co-localize with
gp160 where it is cleaved. Therefore, alternative approaches
are warranted.
In addition, the variability of tissue-speci¢c expression of
convertases, in conjunction with HIV’s ability to infect several
non-lymphocytic cells (dendritic cells, chroma⁄n cells, hepa-
tocytes and glial cells : [14]), suggests that the virus may be
cleaved by various PCs, depending on the infected cell type.
Alternatively, the isolation from lymphocytes of viral enve-
lope glycoprotein maturase (VEM), a non-subtilisin-like pro-
tease able to cleave gp160 in vitro [15], suggested other en-
zymes for gp160 processing. However, VEM has not yet been
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cloned and its role in the gp160 maturation process in infected
cells is still uncertain.
The obvious di⁄culty is that infected cells may contain
redundant activities and that no cell line lacking multiple
members of processing secretory endoproteases is available.
In the absence of an unambiguous system to identify gp160
converting enzymes, we decided to apply subcellular fractio-
nation to a reference tissue, in order to determine the intra-
cellular distribution of speci¢c gp160 cleaving activity, in com-
parison with endogenously expressed furin and PC7/LPC. Rat
liver was selected because furin and PC7/LPC are naturally
expressed at a basal level in liver cells and because fractiona-
tion procedures have been extensively characterized in this
experimental system, in contrast to lymphocytes [16^18].
A low-density subcellular compartment containing a specif-
ic gp160 processing activity was resolved from the trans-Golgi
network (TGN) and from endosomes and probably corre-
sponds to the secretion vesicles dispatched from the TGN.
The gp160 processing activity isolated was also essentially
resolved from the subcellular compartments enriched in furin
and only partially overlapped PC7/LPC. These data suggest
that, at least in the rat liver, furin and PC7/LPC do not
represent the major endoproteases that cleave gp160.
2. Materials and methods
2.1. Sucrose density fractionation
Microsomes (P fraction), prepared as described [18], were brought
to a density of 1.27 g/ml by the slow addition of concentrated sucrose
and layered below either discontinuous or linear sucrose gradients
(from 1.05 to 1.26 g/ml in density) for £otation isopycnic centrifuga-
tion (16 h at 49 000 rpm (VTi 50 rotor, Beckman), i.e. 192U106Ug).
Four fractions were collected from the discontinuous sucrose gra-
dients: the 8.2/33% and 33/36% sucrose interfaces (referred to as
fraction 8/33 and fraction 33/36) and the 36 and 43% sucrose layers
(fraction 36 and fraction 43). To identify integral membrane proteins,
fraction 8/33 (1 mg/ml) was prepared in 200 Wl 10 mM Tris-HCl, pH
7.4, 150 mM NaCl and 1% Triton X-114 at 0‡C. Separation of the
proteins was performed following the procedure of Bordier [19].
14 Fractions were collected from the linear sucrose gradients, weighed
and analyzed for density, enzyme activities and antigen content by
quantitative Western blotting. Distributions of marker enzymes and
those of furin and PC7/LPC have recently been reported [18].
2.2. Endoproteolytic maturation of gp160
Cleavage reactions were performed in 100 Wl of 30 mM Tris-HCl,
150 mM NaCl, 1% Triton X-100, 1 mM CaCl2, pH 7.4, in the pres-
ence of 10 Wl 35S-labelled gp160 (10 000 cpm), puri¢ed as reported
[10], and diluted sucrose gradient fractions (typically 0.7 mg protein/
ml of the 8/33% sucrose interface) at 25‡C. After overnight digestion,
samples were run on an 8% SDS-polyacrylamide gel. Following auto-
radiography, the intensities of the bands were quantitated by densi-
tometry of the X-ray ¢lm. The percentage of speci¢cally cleaved pro-
tein was calculated as described [10]. These endoproteolytic activities
in the liver sucrose gradients were ¢nally normalized according to
Leighton et al. [16].
2.3. Microsequencing of [3H]Leu-labelled gp41
[3H]leucine-radiolabelled gp160 was incubated with fraction 8/33
and the products were separated by 8% polyacrylamide SDS-PAGE
(30U14 cm). The gel was blotted on a PVDF membrane, autoradio-
graphed and the dissected gp41-containing band (noted by an aster-
isk) was layered over a protein ¢lter (Beckman). Microsequencing was
performed on a LF3400 protein sequencer (Beckman). The radioac-
tivity recovered in each cycle was estimated by liquid scintillation
counting (Tri-Carb model 1600CA).
2.4. Free £ow electrophoresis (FFE)
FFE was performed as described [20] except that the sample was
subjected to 0.3% trypsin treatment (0.3 mg trypsin/mg of protein).
Pooled fractions were analyzed for gp160 cleavage as described above
and by Western blotting [18] using a rabbit antiserum anti-TGN38
(TGN marker), provided by G. Banting, University of Bristol [21],
and a mouse hybridoma 6F4C5 against a p54 protein (medial Golgi
marker), provided by A. Tartako¡, Cleveland University [22].
3. Results
3.1. Speci¢c cleavage of gp160 by a low-density subcellular
fraction
Endoproteolytic maturation of newly synthesized HIV
gp160, which is essential for viral infectivity, is mediated with-
in the secretory pathway by host cell proteases. In order to
localize subcellular compartments containing potential gp160
processing activity, rat liver microsomes were isolated by dif-
ferential centrifugation and further resolved in sucrose gra-
dients. First, discontinuous gradients were used and four frac-
tions, collected at the 8/33% and 33/36% sucrose interfaces, as
well the 36 and 43% sucrose layers, were incubated with
[35S]gp160 puri¢ed from vaccinia virus (VV):env-infected
CV-1 cells.
Fluorography of the SDS-PAGE gel (Fig. 1) revealed that
the light fractions (8/33 and 33/36), which are enriched in
Golgi membranes [16], similarly cleaved gp160 into proteins
migrating respectively at 120 and 41 kDa. The bands were
identi¢ed as gp120 and gp41 by Western blotting (not shown).
The absence of other gp160 cleavage products, even at ¢ve
times higher enzyme/substrate ratios (not shown), demon-
strated the speci¢city of the activity isolated in the 8/33 sub-
cellular fraction. In contrast, the high-density 36 and 43 frac-
tions, enriched in rough endoplasmic reticulum (RER) and
lysosomes [16], cleaved gp160 non-speci¢cally, without detect-
able gp120/gp41 intermediate production even after shorter
incubation times.
Upon closer inspection, gp41 generated in vitro by the 8/33
fraction was found to migrate at a slightly higher molecular
Fig. 1. Cleavage of the puri¢ed HIV-1 envelope glycoprotein precur-
sor by rat liver subcellular fractions. Fluorography of a SDS-poly-
acrylamide gel (8% under reducing conditions). Lane 1, [35S]gp160;
lanes 2^5, [35S]gp160 incubated with rat liver microsomes fraction
8/33 (lane 2), 33/36 (lane 3), 36 (lane 4) and 43 (lane 5). Digestions
were performed in 100 Wl of 30 mM Tris-HCl, 150 mM NaCl, 1%
Triton X-100, 1 mM CaCl2, pH 7.4. Positions of molecular weight
markers are indicated at the right. These experiments were repro-
duced s 10 times with identical results.
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weight position than gp41 which was produced by VV:env-
infected CV-1 cells and contaminated the gp160 substrate
preparation. This slight di¡erence in electrophoretic mobility,
barely detectable on the small gels (Fig. 1), was estimated at
V1^2 kDa on longer gels (insert in Fig. 2). A similar di¡er-
ence, also observed when gp41 was produced by convertases
in vitro [10,11], could re£ect glycosylation di¡erences between
the intracellular mature gp41 and that derived from the in
vitro digestion of high-mannose gp160 by the 8/33 fraction.
Alternatively, the molecular weight di¡erence could result
from cleavage at a second potential site (KAKR503sR), lo-
cated eight amino acids upstream of the natural site RE-
KR511sA [23]. To clarify this issue, the NH2-terminal se-
quence of gp41 produced in vitro by the 8/33 fraction was
determined.
3.2. Authenticity of cleavage, as shown by NH2-terminal
sequencing of gp41 generated in vitro by the 8/33 fraction
The 8/33 fraction digestion products of [3H]leucine-labelled
gp160 were separated on a 30 cm long SDS-PAGE and the
upper band was transferred onto a PVDF membrane and
microsequenced. The NH2-terminal sequence revealed the
presence of leucine residues at positions 7, 9 and 12 (Fig. 2),
con¢rming that cleavage occurred between Arg511 and Ala512
of gp160 (KAKR503RVVQREKR511sAVGIGALFLGFLG-
AAG) at the relevant position. These data prompted us to
further characterize the cleavage activity of the 8/33 fraction
and to better de¢ne its subcellular distribution.
3.3. Occurrence of furin and PC7/LPC in the low-density rat
liver subcellular fraction
Since PCs were proposed as the major gp160 processing
enzymes, we examined by immunoblot analyses which of these
were present in the rat liver 8/33 fraction. Furin and PC7/
LPC, migrating respectively at V98 and 92 kDa, were clearly
demonstrated (data not shown, see [18] for a comparable
demonstration on low-density fractions from linear sucrose
gradients), but neither PC1/3 nor PC2 were detected (results
not shown), as expected from the absence of detectable PC1/3
and PC2 mRNA in liver tissue [6]. Due to the lack of anti-rat
PACE4 and PC5/6-speci¢c antibodies, we were unable to
Fig. 2. Microsequence identi¢cation of the gp160 cleavage site by
fraction 8/33. [3H]leucine-gp41 resulting from digestion of gp160 by
fraction 8/33 (upper band noted by an asterisk in the insert) was
separated by SDS-PAGE (8) and sequenced. The deduced leucine
positions are emphasized along the primary sequence following the
gp120/gp41 cleavage site between Arg511 and Ala512 (here numbered
at position 1).
Fig. 3. Density distribution of the gp160 processing activity, furin
and PC7/LPC after isopycnic equilibration of microsomes in sucrose
gradients. Liver was homogenized and a total microsomal fraction
(P) was equilibrated by £otation in a linear sucrose gradient (1.05^
1.26 g/ml in density). 14 Fractions were collected and their cleaving
activity was tested on [35S]gp160. The distribution of gp160 process-
ing activity is represented by the shaded area superimposed on pro-
¢les of the subcellular markers (N-acetyl-L-hexosaminidase: lyso-
somes, p58: cis-Golgi network, 5P-nucleotidase: plasma membrane,
galactosyltransferase: trans-Golgi cisterna, TGN38: TGN) and of
the convertases furin and PC7/LPC. This experiment has been re-
produced once with identical results.
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search for these proteins in the 8/33 fraction, although PACE4
and PC5/6 mRNA are abundantly expressed in the liver [6].
Thus, fraction 8/33 contained at least two members of the
subtilisin-like convertases, furin and PC7/LPC, proposed as
the main candidates for the natural processing of gp160 [8].
We therefore compared some intrinsic characteristics of gp160
processing activity with those of furin and PC7/LPC as well as
their subcellular distribution.
3.4. Partial characterization of gp160 processing activity in the
8/33 low-density fraction
First, the 8/33 fraction was solubilized in Triton X-114 at
0‡C, then separated into aqueous and micellar phases at 20‡C.
gp160 processing activity was mainly (80%) partitioned in the
micellar phase, suggesting its association with integral mem-
branes or amphiphilic enzymes. This result is compatible with
a role of PCs.
Second, the gp160 cleavage activity by the 8/33 low-density
fraction was tested for pH-dependence and was found to ex-
hibit a broad pH range from 5.5 to 9 (data not shown). This is
again compatible with PCs and strongly argues against the
involvement of endosomal or lysosomal proteases such as
cathepsin B, which shows optimal activity at pH 4^5 [24].
Third, since processing of gp160 in living cells is blocked by
intracellular calcium depletion [12,25] and since activity of
PCs depends on calcium [11], the calcium requirement of
gp160 processing activity by the 8/33 low-density fraction
was determined. Cleavage was inhibited by EDTA at concen-
trations well above 2 mM and restored after the addition of
excess CaCl2, demonstrating that the activity is calcium-de-
pendent and does not belong to the metallo-proteinases family
(data not shown).
3.5. Localization of gp160 processing activity in a compartment
lighter than TGN vesicles
To better de¢ne its subcellular localization, cleavage was
monitored in rat liver microsomes that were equilibrated in
continuous sucrose gradients and recently characterized [18].
The distribution pattern of the gp160 processing activity was
analyzed by densitometry and compared with established sub-
cellular markers: 5P-nucleotidase (plasma membrane), N-ace-
tyl-L-hexosaminidase (lysosomes), p58 (cis-Golgi network),
galactosyltransferase (trans-Golgi cisternae) and TGN38. As
previously reported [18], in the absence of ethanol treatment,
furin and PC7/LPC essentially co-distributed with TGN38.
The gp160 processing activity was recovered around a me-
dian density of 1.113 g/ml (Fig. 3). Its distribution was clearly
distinct from the lysosomal (1.203 g/ml) and cis-Golgi net-
work (1.166 g/ml) markers, marginally overlapped the plasma
membrane (1.152 g/ml) and Golgi stacks (1.144 g/ml) distri-
butions and only partially overlapped the TGN (1.133 g/ml),
furin (1.141 g/ml) and PC7/LPC (1.133 g/ml) distributions.
The low abundance of furin and PC7/LPC in the lightest
fractions, that were the most enriched in gp160 processing
activity, suggested that other enzymes, possibly activated by
convertases, were directly responsible for the cleavage of
gp160 into gp120 and gp41 in liver cells. In addition, these
observations excluded a primary location of gp160 processing
activity in lysosomes, the RER, the plasma membrane and the
Golgi stacks. Instead, they indicated that the activity was
associated with a low-density compartment overlapping, but
lighter than the TGN, such as TGN-derived vesicles or endo-
somes. To distinguish between these two possibilities, we re-
sorted to FFE.
3.6. Resolution of gp160 processing activity from endosomes by
FFE
FFE has previously been used to isolate endosomal popu-
lations from cultured cells and tissues [20]. Separation is based
on the di¡erence in the surface charge of particles (proteins,
membrane-bound organelles) subjected to electrophoresis.
Early and late endosomes were labelled by in situ perfusion
of rat liver with £uid phase endocytosis markers, using respec-
tively horseradish peroxidase (HRP) for 1 min and FITC-dex-
tran for 4 min of pulse and 10 min of chase. After perfusion,
light microsomes were isolated and separated by FFE (Fig.
4A). HRP- and FITC-dextran-labelled endosomes essentially
Fig. 4. FFE of low-density microsomes. Early and late endosomes
were labelled with HRP and FITC-dextran by in situ perfusion for
1 min or using a 4 min pulse and 10 min chase at 37‡C, respec-
tively. Low-density microsomes were then injected into the FFE
chamber at the cathodic site (opposite to outlet # 66), separated by
FFE and the distributions of protein (triangles), HRP (squares) and
FITC-dextran (circles) were determined (A). Positions of the anode
and the cathode are indicated at the top. Data are expressed as per-
centage of the total amount recovered after FFE. Fractions were
grouped in four pools (I, II, III and IV), their endosomal content
(mean of HRP- and FITC-dextran-labelled endosomes) was calcu-
lated (B) and the enzymatic activity of each of these was tested on
[35S]gp160 (C). Immunoblot analyses were performed on the four
pools using antibodies against the TGN38 protein (D) and p54 pro-
tein (E). This experiment has been reproduced once with identical
results.
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co-migrated as a major intermediate peak. In contrast, protein
distribution was bimodal, one peak co-migrating with endo-
somes and the other peak extending towards the cathode.
To localize the gp160 endoproteolytic activity, the FFE
fractions were concentrated in four pools and each was tested
on [35S]gp160. The speci¢c cleavage activity was the highest in
pool III, which was largely depleted of endosomes, and lower
in pool II, which was more enriched in endosomes (cf. Fig. 4B
and C), pointing to a compartment distinct from the endo-
somes. In contrast, the distribution pro¢le of the gp160 proc-
essing activity after FFE partially overlapped those of the
Golgi stacks (marker p54, Fig. 4D) and the TGN (marker
TGN38, Fig. 4E). Taken together, continuous density gra-
dient and FFE analyses suggested that the gp160 processing
activity localized in vesicles dispatched from the TGN such as
secretory vesicles.
4. Discussion
In the present work, we have identi¢ed in the liver an en-
doproteolytic activity of the appropriate speci¢city towards
gp160 and have compared its properties and subcellular dis-
tribution with those of convertases that cleave gp160 in vitro
or when overexpressed in cultured cells. The unusually high
concentration of EDTA required to inhibit cleavage and the
distinct distribution of this activity from furin and PC7/LPC
argue against these two PCs being the only actors responsible
for gp160 processing activity in our system.
Even though biosynthesis of HIV-1 envelope glycoprotein
gp160 and its endoproteolytic processing into gp41 and gp120
have been extensively studied, the exact subcellular localiza-
tion of the cleavage step is still uncertain. The best candidates
are the Golgi complex, the TGN or the secretory vesicles [2^
5]. The present subcellular fractionation study identi¢es a spe-
ci¢c endoproteolytic gp160 processing activity that is not as-
sociated with lysosomes, endoplasmic reticulum and Golgi
stacks, but rather with very low-density vesicles. Since these
vesicles could correspond either to TGN-derived vesicles [18]
or to endosomes [17], FFE was used and the ensuing results
argued against a primary location of gp160 processing activity
in early and late endosomes. Furthermore, in contrast to the
gp160 processing activity that partitioned in the Triton X-114
micelle phase and was maximal at a broad neutral pH, known
endosomal/lysosomal proteases are soluble enzymes and act at
low pH. Therefore, we suggest that the gp160 processing ac-
tivity localizes in TGN-derived vesicles. This hypothesis is
compatible with temperature reversion experiments showing
that, when HIV-infected Jurkat cells were incubated at
20‡C, gp160 accumulated in the TGN and was not cleaved.
When the temperature was shifted to 37‡C, secretion resumed
and gp160 was processed, suggesting that the endoproteolytic
processing of gp160 takes place after exit from the TGN
[5].
The nature of the cleaving enzyme(s) remains elusive. While
liver expresses endogenous furin and PC7/LPC, both reported
as the main gp160 cleaving enzymes [8], particles containing
the gp160 processing activity were largely depleted of furin
and did not strictly co-distribute with PC7/LPC. In analytical
subcellular fractionation, due to the polydisperse nature of
biological particles, evidence of overlapping between an activ-
ity and a particular enzyme cannot by itself demonstrate phys-
ical linkage, whereas dissociation is good evidence of distinct
activities and compartments. In addition, a single activity
should strictly correlate with the distribution of the presump-
tive actor. The lower right panel of Fig. 3 clearly shows that
the peaks of gp160 endoproteolytic activity and PC7/LPC are
distinct and that about half of PC7/LPC is associated with
fractions 5^7, where no gp160 endoproteolytic activity can be
detected. The lack of proportionality between PC7/LPC and
gp160 endoproteolytic activity in the gradient fractions indi-
cates that an activity distinct from PC7/LPC has been identi-
¢ed that is crucial for gp160 maturation in this experimental
system.
Since furin displays a similar subcellular localization among
various cell lines [26], we suggest that HIV-1 gp160 processing
could be mainly e¡ected by endoproteases other than furin
and PC7/LPC. This suggestion is entirely consistent with three
other lines of experimental evidence. First, two furin-defective
cell lines, RPE.40 and LoVo cells, are able to correctly process
gp160 [27,28]. Second, gp160 processing in COS-1 cells is not
inhibited by the co-expression of FUR-rK2-macroglobulin
(M), an K2M mutant known to drastically inhibit endogenous
substrate processing by furin, suggesting that furin and gp160
do not share the same secretory pathway [29]. Third, gp160 is
a poor substrate for furin, which is about 1000 times less
sensitive to cleavage by the puri¢ed enzyme than anthrax
toxin PA [28,30].
Could other convertases do the job? Northern blot analyses
have previously revealed that PC5/6 and PACE4 are also ex-
pressed in rat liver and e⁄ciently cleave gp160 in vitro and in
cultured cells [11,12]. Although the membrane-bound forms of
PC5/6 (PC5/6-B) [31] and PACE4 (PACE4-E) [32] are concen-
trated in the TGN, they could cycle to the cell surface and
may also play a role in gp160 processing. However, in the
absence of good antibodies against these enzymes which
would work on Western blots, their possible contribution to
the processing of gp160 could not be addressed.
Finally, the activation of a rate-limiting non-subtilisin en-
zyme by convertases can be envisaged. Indeed, two reports
have implied that convertases may activate another, as yet
unde¢ned, gp160 processing enzyme [8,28]. PC7/LPC has
been proposed to interact with other cellular proteins or to
activate another enzyme, since it is able to cleave gp160 only
by co-expression, but not in vitro [8]. PACE4 was also shown
to participate in the activation of a protease in the furin-de-
¢cient RPE.40 cells, which e⁄ciently convert gp160 into
gp120/gp41 [28]. VEM, the non-subtilisin protease puri¢ed
from a lymphocytic Golgi fraction and able to cleave gp160
into its two bona ¢de subunits, remains an interesting candi-
date [15]. Finally, it cannot be excluded that several enzymes
are able to cleave gp160, as the exploitation of redundant
systems is a well-conceivable viral strategy for this critical
step for HIV activation.
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